Uniplan Investment Counsel, Inc. Seelos Therapeutics, Inc. Transaction History

Uniplan Investment Counsel, Inc.

$1.08 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.66 - $1.22 $2,451 - $4,531	-3,714 Reduced 0.33%	1,123,101 $1.34 Million
Q1 2023 May 15, 2023	SELL	$0.59 - $1.04 $29,910 - $52,722	-50,695 Reduced 4.31%	1,126,815 $778,000
Q4 2022 Feb 14, 2023	SELL	$0.66 - $259.46 $863,159 - $339 Million	-1,307,817 Reduced 52.62%	1,177,510 $799,000
Q3 2022 Nov 14, 2022	SELL	$0.65 - $278.68 $9,024 - $3.87 Million	-13,884 Reduced 0.56%	2,485,327 $2.56 Million
Q2 2022 Aug 15, 2022	BUY	$0.51 - $0.93 $476,649 - $869,183	934,606 Added 59.73%	2,499,211 $1.7 Million
Q1 2022 May 16, 2022	BUY	$0.84 - $1.71 $11,966 - $24,360	14,246 Added 0.92%	1,564,605 $1.31 Million
Q4 2021 Feb 14, 2022	BUY	$1.59 - $2.38 $6,714 - $10,050	4,223 Added 0.27%	1,550,359 $2.53 Million
Q3 2021 Nov 15, 2021	SELL	$1.69 - $2.89 $5,751 - $9,834	-3,403 Reduced 0.22%	1,546,136 $3.73 Million
Q2 2021 Aug 13, 2021	BUY	$2.64 - $6.32 $53,919 - $129,079	20,424 Added 1.34%	1,549,539 $4.09 Million
Q1 2021 May 14, 2021	SELL	$1.35 - $4.99 $537,193 - $1.99 Million	-397,921 Reduced 20.65%	1,529,115 $7.63 Million
Q4 2020 Feb 12, 2021	SELL	$0.74 - $2.01 $78,428 - $213,027	-105,984 Reduced 5.21%	1,927,036 $3.04 Million
Q3 2020 Nov 13, 2020	BUY	$0.6 - $1.25 $405,951 - $845,731	676,585 Added 49.88%	2,033,020 $1.9 Million
Q2 2020 Aug 14, 2020	SELL	$0.42 - $1.51 $299,328 - $1.08 Million	-712,686 Reduced 34.44%	1,356,435 $1.37 Million
Q1 2020 May 15, 2020	BUY	$0.47 - $1.56 $660,182 - $2.19 Million	1,404,644 Added 211.39%	2,069,121 $1.01 Million
Q4 2019 Feb 14, 2020	BUY	$0.72 - $1.52 $4,332 - $9,145	6,017 Added 0.91%	664,477 $890,000
Q3 2019 Nov 14, 2019	SELL	$0.92 - $2.15 $31,429 - $73,450	-34,163 Reduced 4.93%	658,460 $604,000
Q2 2019 Aug 14, 2019	BUY	$2.11 - $3.3 $1.46 Million - $2.29 Million	692,623 New	692,623 $1.52 Million

Others Institutions Holding SEEL

# of Institutions

Shares Held

40.5K

Call Options Held

Put Options Held

Asset Management Corp

40.5K
Shares

$15,390
0.02% of portfolio

View Full List

About SEELOS THERAPEUTICS, INC.

Ticker SEEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 106,691,000
Market Cap $40.5M
Description
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...

More about SEEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Uniplan Investment Counsel, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Uniplan Investment Counsel, Inc. with notifications on news.

Account